| Next 10 |
Ad
TSVT News and Press 2seventy bio Inc.
News | 2seventy bio Inc. (NASDAQ:TSVT)
-
2023-12-06 16:37:38 ET Verint Systems ( VRNT ) +11% . ZyVersa Therapeutics ( ZVSA ) +6% . Couchbase ( BASE ) +4% . Grayscale Solana Trust ( OTCQB:GSOL ) +4% . Cabaletta ( CABA ) +3% . Vivid Seats ( SEAT ) ...
-
2023-12-06 14:48:10 ET Penny Stocks – How News Makes These Small Caps Soar or Plunge Penny stocks , securities with share prices under $5, offer investors a chance at exponential returns with little upfront investment. However, investing wisely in penny stocks require...
-
2023-12-06 14:45:26 ET More on Bristol-Myers Bristol-Myers Squibb Is A Great Buy, But These 5+% Yielding Bargains Are Better Bristol-Myers Squibb: The Patent Expiry Challenge Bristol Myers Squibb: A Bitter Pill But Still A Buy Bristol Myers gets priority revi...
-
2seventy bio, Inc. (NASDAQ: TSVT), (“2seventy” or “the Company”), a leading immuno-oncology cell therapy company, today issued the following statement reiterating its commitment to maximizing shareholder value: As we indicated last month, the Board has commenced a ...
-
2023-12-06 12:32:02 ET More on 2seventy bio 2seventy bio, Inc. (TSVT) Q3 2023 Earnings Call Transcript bluebird bio And 2seventy bio - Spinner And Spun: The Better Bet In Cell Therapy FDA probing serious risk of T-cell malignancies in CAR-T cell therapy patients (upd...
-
2023-11-28 10:52:22 ET The U.S. Food and Drug Administration (FDA) on Tuesday said it was looking into reports of T-cell malignancies in patients who have been treated with CAR-T cell immunotherapies directed towards the proteins BCMA and CD19. The regulator said it had determined that ...
-
2023-11-20 12:59:05 ET Gainers: Mira Pharmaceuticals ( MIRA ) +58% . YPF ADR ( YPF ) +39% . Altamira Therapeutics Ltd ( CYTO ) +39% . ProKidney Corp ( PROK ) +35% . Soluna Holdings ( SLNH ) +32% . Safety Shot ( SHOT ) +...
-
2023-11-20 08:24:45 ET Losers: Syntec Optics Holdings ( OPTX ) -15% . Safe and Green Development Corp ( SGD ) -14% . Plus Therapeutics ( PSTV ) -14% reports new interim reSPECT-GBM phase 2 trial data at the society for NeuroOncology annual meeting. ...
-
2023-11-20 07:34:54 ET More on Bristol-Myers Bristol Myers Squibb: Bright Future Ahead Bristol-Myers Squibb Company (BMY) Management Presents at Jefferies London Healthcare Conference (Transcript) Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS Bio...
-
Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) today announced the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) will meet to review data supporting the supplemental Biologics License Application (sBLA) for Abecma (ide...
Stock Information
Get TSVT Alerts
News, Short Squeeze, Breakout and More Instantly...
2seventy bio Inc. Company Name:
TSVT Stock Symbol:
NASDAQ Market:
Ad
-
2023-12-06 14:48:10 ET Penny Stocks – How News Makes These Small Caps Soar or Plunge Penny stocks , securities with share prices under $5, offer investors a chance at exponential returns with little upfront investment. However, investing wisely in penny stocks require...
-
2seventy bio, Inc. (NASDAQ: TSVT), (“2seventy” or “the Company”), a leading immuno-oncology cell therapy company, today issued the following statement reiterating its commitment to maximizing shareholder value: As we indicated last month, the Board has commenced a ...
-
Tuesday, the FDA said it received reports of patients developing T-cell malignancies, including chimeric antigen receptor CAR-positive ly...